Paddison Lab’s Ding wins $50,000 fellowship

Yu Ding will use the Association of American Cancer Institutes’ award to propel glioma genomic research
Dr. Yu Ding
Dr. Yu Ding is working to determine which genes are implicated in glioma, a type of brain cancer, as well as to establish potential therapeutic targets. Photo by Dean Forbes

Dr. Yu Ding, a postdoctoral research fellow in the Human Biology Division’s Paddison Lab, was awarded a one-year, $50,000 translational cancer research fellowship from the Association of American Cancer Institutes for his groundbreaking work on glioma, a type of brain cancer.

Using genomewide RNAi screens of self-renewing glioma neural stem cells and neural stem cells, Ding is working to determine which genes are implicated in glioma, as well as to establish potential therapeutic targets.

AACI fellowships provide career development support to individuals working in clinical and/or translational cancer research. The goal is to assist trainees in becoming a high-caliber, productive independent researchers with an enduring focus on the importance of translational research to cancer.

AACI includes 95 leading cancer research centers in the U.S. Its membership roster includes National Cancer Institute-designated centers and academic-based cancer research programs that receive NCI support. AACI is dedicated to promoting the nation’s leading research institutions’ efforts to eradicate cancer through a comprehensive and multidisciplinary program of cancer research, treatment, patient care, prevention, education and community outreach.

Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.